Targeted drug delivery and image-guided therapy of heterogeneous ovarian cancer using HER2-targeted theranostic nanoparticles

Keyphrases

• Ovarian Cancer 100%
• Theranostic Nanoparticles 100%
• Targeted Theranostics 100%
• Image-guided Therapy 100%
• Targeted Drug Delivery 100%
• Drug Images 100%
• HER2 Expression 100%
• HER2-targeted Therapy 100%
• Primary Tumor 75%
• Residual Tumor 75%
• Tumor 50%
• Magnetic Resonance Imaging 50%
• Effective Treatment 50%
• Magnetic Iron Oxide Nanoparticles 50%
• Human Epidermal Growth Factor Receptor 2 (HER2) 50%
• Tumor Tissue 50%
• Cisplatin 50%
• Metastatic Tumor 50%
• Therapeutic Response 50%
• Cancer Xenograft Model 50%
• Nanoparticle Drug Delivery 50%
• Ovarian Cancer Xenograft 50%
• Nanoparticles 25%
• Histological Analysis 25%
• Therapeutic Efficacy 25%
• Imaging Detection 25%
• Optical Imaging 25%
• Tumor Cells 25%
• Spectroscopic Imaging 25%
• Optical Signal 25%
• Near-infrared Dye 25%
• Iron Oxide Nanoparticles 25%
• Response to Therapy 25%
• Nude Mice 25%
• In Vivo Molecular Imaging 25%
• Drug Resistance 25%
• Polymer-coated 25%
• Targeted Cancer Therapy 25%
• Cancer Therapy 25%
• Systemic Delivery 25%
• Imaging Analysis 25%
• Highly Heterogeneous 25%
• Metastatic Cells 25%
• Amphiphilic Polymer 25%
• Cancer Drugs 25%
• Cancer Heterogeneity 25%
• Excise 25%
• Therapy-resistant 25%
• Proliferating Cells 25%
• Treatment Protocol 25%
• Lung Metastasis 25%
• Resistant Mechanism 25%
• Resistance to Chemotherapy 25%
• Human Ovarian Cancer 25%
• Integrated Treatment 25%
• Drug-resistant Tumor 25%
• Drug Accumulation 25%
• Chemotherapy Drugs 25%
• Debulking Surgery 25%
• Ovarian Cancer Screening 25%
• Peritoneal Metastasis 25%
• Primary Peritoneal 25%
• Nanoparticle Retention 25%
• Affibody 25%
• Metastatic Ovarian Cancer 25%

Medicine and Dentistry

• Neoplasm 100%
• Nanoparticle 100%
• Ovarian Cancer 100%
• Metastatic Carcinoma 37%
• Ultrasmall Superparamagnetic Iron Oxide 37%
• Primary Tumor 37%
• Tumor Cell 25%
• Treatment Response 25%
• Nuclear Magnetic Resonance 25%
• Cancer Therapy 25%
• Tumor Xenograft 25%
• Cisplatin 25%
• Molecular Imaging 12%
• Optical Imaging 12%
• Malignant Neoplasm 12%
• Spectroscopic Imaging 12%
• Cell Proliferation 12%
• Debulking Surgery 12%
• Cytoreductive Surgery 12%
• Combination Therapy 12%
• Drug Resistance 12%
• Lung Metastasis 12%
• Molecularly Targeted Therapy 12%
• Drug Accumulation 12%
• Peritoneum Metastasis 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• Neoplasm 100%
• Targeted Drug Delivery 100%
• Ovary Cancer 100%
• Malignant Neoplasm 33%
• Iron Oxide Nanoparticle 33%
• Metastasis 33%
• Primary Tumor 33%
• Chemotherapy 22%
• Cisplatin 22%
• Combination Therapy 11%
• Nude Mouse 11%
• Drug Resistance 11%
• Optical Imaging 11%
• Lung Metastasis 11%
• Peritoneum Metastasis 11%